Ipsos Healthcare, a division of Ipsos Group, is a leading global market research firm headquartered in the United States. Established in 1975, the company has carved a niche in the healthcare industry, providing insights and analytics that drive strategic decision-making for pharmaceutical, biotechnology, and medical device companies. With a strong presence in North America, Europe, and Asia-Pacific, Ipsos Healthcare offers a range of services, including market access, brand health tracking, and patient experience research. Their unique approach combines advanced methodologies with deep industry expertise, ensuring clients receive actionable insights tailored to their specific needs. Recognised for its commitment to quality and innovation, Ipsos Healthcare has achieved significant milestones, positioning itself as a trusted partner in the healthcare sector. The firm’s dedication to understanding patient perspectives and market dynamics sets it apart in a competitive landscape.
How does Ipsos Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Ipsos Healthcare's score of 54 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ipsos Healthcare, headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. However, the organisation is part of a corporate family that includes Ipsos SA, from which it inherits emissions data and climate commitments. Ipsos SA has established various climate initiatives, including commitments to the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). These initiatives aim to enhance transparency and accountability in carbon emissions management. While specific reduction targets for Ipsos Healthcare are not detailed, the overarching goals set by Ipsos SA reflect a commitment to reducing carbon footprints across its operations. As a current subsidiary of Ipsos SA, Ipsos Healthcare aligns with the climate strategies and performance metrics of its parent company, which is actively engaged in sustainability efforts. The absence of specific emissions data highlights the need for further disclosure and commitment to climate action within the healthcare sector.
Access structured emissions data, company-specific emission factors, and source documents
| 2013 | 2019 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|
| Scope 1 | 6,953,528 | 0,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 14,737,328 | 0,000,000 | 00,000,000 | 00,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 30,201,144 | 000,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 |
Ipsos Healthcare's Scope 3 emissions, which increased by 4% last year and increased by approximately 377% since 2013, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 81% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Ipsos Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.